Insta
Auto Sector Blues Continue As Market Leader Maruti Suzuki Sees Sales Falling 24.4 Per Cent In September
Swarajya Staff
Oct 02, 2019, 01:31 PM | Updated 01:31 PM IST
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Leading Indian automaker Maruti Suzuki India (MSI) has continued to see a decline in sales in September, figures released on Tuesday (1 October) show, reports PTI. The company’s vehicle sales for the month fell 24.4 per cent to 1,22,640 from 1,62,290 a year ago.
The fall in domestic vehicle sales was marginally worse than the fall in exports, with Indian buyers buying only 1,12,500 units compared to 1,53,550 in the same period last year, a drop of 26.7 per cent. Exports declined by 17.8 per cent to 7,188 units compared to 8,740 units the year before.
The one segment which remained relatively sturdy in the face of the slowdown was utility vehicles, with sales in this category remaining stagnant at 21,526 units compared to 21,639 in September 2018.
The auto sector has been undergoing a period of declining sales for the past several months now, with sales of both commercial and passenger vehicles hit hard. Apart from a general slowdown in economic activity, another factor blamed for this is that consumers are waiting for BS-VI norms to kick in next year to make big ticket car purchases.
Save & read from anywhere!
Bookmark stories for easy access on any device or the Swarajya app.
Introducing ElectionsHQ + 50 Ground Reports Project
The 2024 elections might seem easy to guess, but there are some important questions that shouldn't be missed.
Do freebies still sway voters? Do people prioritise infrastructure when voting? How will Punjab vote?
The answers to these questions provide great insights into where we, as a country, are headed in the years to come.
Swarajya is starting a project with an aim to do 50 solid ground stories and a smart commentary service on WhatsApp, a one-of-a-kind. We'd love your support during this election season.
Click below to contribute.